Rising Cancer Prevalence Driving The Intravenous Solutions Market: Critical Driver Shaping the Global Intravenous Solutions Market in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Intravenous Solutions Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for intravenous solutions has experienced robust expansion recently and is projected to increase from $14 billion in 2024 to $14.91 billion in 2025, reflecting a compound annual growth rate of 6.5%; this upward trend during the past period is linked to several factors, including a surge in surgical operations, the increasing incidence of long-term illnesses, the broadening scope of home-based medical care, strict rules aimed at guaranteeing the safety of medical products, greater emphasis placed on maintaining patient fluid balance, and worldwide efforts towards better readiness for emergencies.

Intravenous Solutions Market Size Forecast: What's the Projected Valuation by 2029?
The intravenous solutions market is projected to experience strong growth in the coming years, reaching $20.1 billion by 2029 at a compound annual growth rate (CAGR) of 7.7%. The anticipated growth during the forecast period will be driven by population expansion and aging, an increase in surgical procedures, a rise in infectious disease cases, advancements in telemedicine and remote patient monitoring, a focus on preventive healthcare, investments in global health security, and growing patient-centered care trends. Key trends expected in the market include rising demand for parenteral nutrition solutions, growing use of pre-mixed IV solutions, expansion of home infusion therapies, development of electrolyte-balanced solutions, introduction of novel drug additives and adjuncts, and integration of smart IV monitoring systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

What Are the Drivers Transforming the Intravenous Solutions Market?
The escalating incidence of cancer is anticipated to act as a significant catalyst for the expansion of the intravenous solutions sector in the future. Cancer, defined by malignant cell proliferation that allows tissues to be encroached upon and distant sites invaded, frequently necessitates the use of IV solutions for administering chemotherapeutic agents and ensuring patients remain adequately hydrated throughout treatment regimens. Illustratively, projections released in February 2024 by the World Health Organization, an intergovernmental body headquartered in Switzerland, forecast that by the year 2050, there will be more than 35 million new cancer diagnoses annually, marking a substantial 77% surge from the roughly 20 million cases documented in 2022, thus underscoring how the rising burden of cancer fuels the market growth for intravenous solutions.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

What Long-Term Trends Will Define the Future of the Intravenous Solutions Market?
Key players within the intravenous solutions sector are concentrating their efforts on engineering novel syringe designs, specifically pre-filled and ready-to-administer formats, as a strategy to sharpen their competitive positioning. These pre-filled and instantly usable syringes come loaded with the necessary medication, engineered for direct administration without the need for manual preparation or filling procedures. Illustrating this trend, the American healthcare firm GENIXUS Corp. introduced KinetiXTM Rocuronium Bromide Injection in August 2023, offering it in 5 mL and 10 mL ready-to-administer (RTA) syringe formats. The construction material for these syringes involves a resilient, clear polymer, thereby mitigating the hazards traditionally linked with glass containers. Given their pre-filled status and immediate usability, these syringes contribute to efficiency gains and a decrease in mistakes related to medication handling. The administered Rocuronium bromide injection is strictly intended for intravenous application and boasts several crucial features, such as compatibility with RFID technology via KitCheck, which represents the newest advancement in kit and tray oversight, along with user-friendly labeling and a plunger rod distinguished by color coding to facilitate quick recognition.

Which Segments in the Intravenous Solutions Market Offer the Most Profit Potential?
The intravenous solutionsmarket covered in this report is segmented -

1) By Product: Total Parenteral Nutrition; Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates; Vitamins And Minerals; Single Dose Amino Acids; Parenteral Lipid Emulsion; Other Nutrients
3) By Application: Basic Intravenous (IV) Solution; Nutritional Intravenous (IV) Solution; Blood Intravenous (IV) Solution; Drug Intravenous (IV) Solution; Irrigation Intravenous (IV) Solution
4) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Home Care Settings

Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions; Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

Which Firms Dominate the Intravenous Solutions Market by Market Share and Revenue in 2025?
Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, dic*kinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

Which Regions Offer the Highest Growth Potential in the Intravenous Solutions Market?
North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.